CSIMarket
Pacira Biosciences inc   (PCRX)
Other Ticker:  
 
 

Pacira Biosciences Inc 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



PCRX Annual Income from Cont. Operations Growth

2022
2021
2019
2018
2017
Y / Y Annual Income from Cont. Operations Change -62.1 % - - - -
Annual Income from Cont. Operations (in millions $) $15.91 $41.98 $-11.02 $-2.04 $-47.48


Annual Income from Cont. Operations Growth Comment
Pacira Biosciences Inc experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2022 by -62.1% to $ 15.91 millions, compare to $ 41.98 in Annual Income from Cont. Operations reported in the previous year. Pacira Biosciences Inc 's Income from Continued Operations decline slowed form -481.08 % contraction in the fiscal year 2021.

Pacira Biosciences Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd -99.39 %$ 88.131  millions
Fulgent Genetics Inc -71.97 %$ 141.923  millions
Uniqure N v